"10.1371_journal.pone.0018165","plos one","2011-04-15T00:00:00Z","Ume L Abbas; Gregory Hood; Arthur W Wetzel; John W Mellors","Department of Infectious Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America; Pittsburgh Supercomputing Center, Pittsburgh, Pennsylvania, United States of America; Division of Infectious Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America","Wrote the paper: ULA.Model formulation: ULA JWM. Model analyses: ULA. Computer programming and multivariate sensitivity analyses at the Pittsburgh Supercomputing Center: GH AWW. Interpreted results and edited the manuscript: JWM.","John W. Mellors reports that he is a consultant to Gilead Sciences, Merck, and RFS Pharmaceuticals, has received grant support from Merck, and owns share options in RFS Pharmaceuticals. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","04","Ume L Abbas","ULA",4,TRUE,NA,NA,NA,1,TRUE,FALSE,FALSE,0,NA,FALSE
